Richard A. Heyman - Director at Enliven Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
ELVN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Richard A. Heyman - trading volume in the past year for Enliven Therapeutics, Inc.

Holdings reported by Richard A. Heyman for Enliven Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 132K $3.62M $27.51 Jul 31, 2024 Direct
Common Stock 27.9K $768K $27.50 Jul 31, 2024 Indirect
Stock Option (right to buy) 29.2K Feb 13, 2024 Direct Common Stock

Transactions reported by Richard A. Heyman for Enliven Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership